Skip to main content

J&J Sued By New Mexico Over Talcum Powder

J&J Sued By New Mexico Over Talcum Powder

J&J Sued By New Mexico Over Talcum Powder

Introduction

The state of New Mexico filed a lawsuit against Johnson & Johnson(J&J) and Valeant Pharmaceuticals, alleging that their talc-based products were laced with asbestos while explicitly marketing to African-American and Hispanic New Mexican women and children.

The complaint was filed on January 2 in state court in Santa Fe by Attorney General Hector Balderas. Although J&J is facing thousands of lawsuits over its talc products, New Mexico is the first state seeking punitive damages through legal action.

The state alleges that J&J targeted the African-American and Hispanic women and children for robust marketing as people of these two ethnicities have a higher rate of people using its baby powder.

The brief also states that a study in 1995 found a 27 percent increase in ovarian cancer for women who used talc on a regular basis in abdominal or vaginal areas.

Nearly 14,000 Talcum Powder and Shower-to-Shower lawsuits are consolidated under multidistrict litigation MDL No. 2738; In Re: Johnson & Johnson Talcum Powder Products Marketing, Sales Practices, and Products Liability Litigation. Lawsuits are also pending in a coordinated California proceeding under Judicial Council Coordinated Proceeding No. 4877.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Cencora Directors Settle Opioid Oversight Case for $111M

Categories: Opioids

Cencora has agreed to pay $111.3 million to settle a shareholder lawsuit accusing the company’s directors of failing to prevent the unlawful distribution of opioids

Study Finds CPAP May Harm Low-Risk Sleep Apnea Patients

A new study has cast doubt on the long-standing belief that continuous positive airway pressure (CPAP) machines significantly reduce heart…

FDA Adds New Warnings on Long-Term Opioid Risks

Categories: Opioids

Federal regulators have raised concerns that many opioid medications were approved for prolonged use without sufficient clinical evidence confirming their safety.

✍️ FREE — 2,800 Pages Legal Process Outsourcing Trial!                 
No Contract. No Risk — Full Mass Tort + LPO Access, Free!

Only 10 Firms Accepted—Offer Ends August 31!